30.58
price down icon0.94%   -0.29
pre-market  Vorhandelsmarkt:  30.60   0.02   +0.07%
loading
Schlusskurs vom Vortag:
$30.87
Offen:
$30.93
24-Stunden-Volumen:
2.72M
Relative Volume:
0.62
Marktkapitalisierung:
$15.69B
Einnahmen:
$11.89B
Nettoeinkommen (Verlust:
$-560.00M
KGV:
-27.80
EPS:
-1.1
Netto-Cashflow:
$191.00M
1W Leistung:
+0.49%
1M Leistung:
+0.16%
6M Leistung:
-8.20%
1J Leistung:
-9.66%
1-Tages-Spanne:
Value
$30.48
$31.04
1-Wochen-Bereich:
Value
$29.72
$31.04
52-Wochen-Spanne:
Value
$26.25
$40.49

Baxter International Inc Stock (BAX) Company Profile

Name
Firmenname
Baxter International Inc
Name
Telefon
(224) 948-2000
Name
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Name
Mitarbeiter
38,000
Name
Twitter
@baxter_intl
Name
Nächster Verdiensttermin
2024-11-08
Name
Neueste SEC-Einreichungen
Name
BAX's Discussions on Twitter

Vergleichen Sie BAX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
BAX
Baxter International Inc
30.58 15.62B 11.89B -560.00M 191.00M -1.10
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
552.41 196.08B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
173.01 49.62B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.38 43.30B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
244.76 36.04B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
80.12 15.87B 3.93B 415.40M 384.70M 2.06

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-26 Fortgesetzt Goldman Buy
2025-02-24 Hochstufung Argus Hold → Buy
2025-02-20 Fortgesetzt Barclays Overweight
2024-07-15 Herabstufung Morgan Stanley Equal-Weight → Underweight
2024-05-30 Eingeleitet Goldman Neutral
2024-05-10 Herabstufung TD Cowen Buy → Hold
2023-05-30 Fortgesetzt Morgan Stanley Equal-Weight
2023-03-29 Eingeleitet UBS Neutral
2023-01-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-01-05 Herabstufung Raymond James Outperform → Mkt Perform
2023-01-03 Herabstufung BofA Securities Buy → Neutral
2022-12-19 Herabstufung JP Morgan Overweight → Neutral
2022-12-15 Herabstufung Deutsche Bank Buy → Hold
2022-12-12 Herabstufung Citigroup Buy → Neutral
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Hold
2022-06-24 Herabstufung Wells Fargo Overweight → Equal Weight
2022-04-04 Herabstufung Goldman Neutral → Sell
2022-03-02 Fortgesetzt BofA Securities Buy
2022-02-18 Bestätigt KeyBanc Capital Markets Overweight
2022-02-18 Bestätigt Morgan Stanley Overweight
2022-02-18 Bestätigt Raymond James Outperform
2022-02-18 Bestätigt Stifel Buy
2022-02-18 Bestätigt UBS Neutral
2022-02-18 Bestätigt Wells Fargo Overweight
2022-02-11 Eingeleitet Goldman Neutral
2022-01-07 Fortgesetzt Citigroup Buy
2022-01-07 Hochstufung Morgan Stanley Equal-Weight → Overweight
2021-09-13 Hochstufung Cowen Market Perform → Outperform
2021-09-03 Hochstufung Barclays Equal Weight → Overweight
2021-05-25 Eingeleitet Barclays Equal Weight
2021-01-29 Herabstufung Piper Sandler Overweight → Neutral
2021-01-06 Herabstufung UBS Buy → Neutral
2020-12-15 Herabstufung Goldman Buy → Neutral
2020-10-01 Hochstufung Citigroup Neutral → Buy
2020-09-04 Herabstufung Argus Buy → Hold
2020-06-24 Eingeleitet Oppenheimer Outperform
2020-03-19 Hochstufung Stifel Hold → Buy
2020-03-18 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2020-03-05 Eingeleitet Citigroup Neutral
2020-02-13 Eingeleitet Goldman Buy
2020-01-02 Hochstufung Evercore ISI In-line → Outperform
2019-12-17 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-06-26 Eingeleitet KeyBanc Capital Markets Sector Weight
2019-04-08 Herabstufung Evercore ISI Outperform → In-line
2019-01-02 Hochstufung Citigroup Neutral → Buy
2019-01-02 Hochstufung Morgan Stanley Underweight → Overweight
2018-11-02 Hochstufung Argus Hold → Buy
2018-10-16 Eingeleitet Barclays Underweight
2018-05-17 Fortgesetzt Piper Jaffray Overweight
2018-02-06 Bestätigt Citigroup Neutral
2018-01-03 Eingeleitet Evercore ISI Outperform
2018-01-03 Hochstufung Raymond James Mkt Perform → Outperform
Alle ansehen

Baxter International Inc Aktie (BAX) Neueste Nachrichten

pulisher
May 27, 2025

BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 | BAX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 - FinancialContent

May 27, 2025
pulisher
May 27, 2025

GF Fund Management CO. LTD. Takes Position in Baxter International Inc. (NYSE:BAX) - MarketBeat

May 27, 2025
pulisher
May 25, 2025

Do These 3 Checks Before Buying Baxter International Inc. (NYSE:BAX) For Its Upcoming Dividend - simplywall.st

May 25, 2025
pulisher
May 25, 2025

We Wouldn't Be Too Quick To Buy Baxter International Inc. (NYSE:BAX) Before It Goes Ex-Dividend - Yahoo Finance

May 25, 2025
pulisher
May 23, 2025

Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Hold" by Analysts - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Raiffeisen Bank International AG Purchases Shares of 76,587 Baxter International Inc. (NYSE:BAX) - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Baxter launches room-temperature collagen sealing pad - MassDevice

May 20, 2025
pulisher
May 20, 2025

Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS) - PR Newswire

May 20, 2025
pulisher
May 19, 2025

Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & SuppliesDiversified Stocks - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Parkwood LLC Invests $10.75 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of “Hold” from Analysts - Defense World

May 18, 2025
pulisher
May 18, 2025

Baxter’s Q4 Performance Beats Expectations - Medical Product Outsourcing

May 18, 2025
pulisher
May 14, 2025

Baxter at Bank of America 2025 Healthcare Conference: Strategic Shifts and Growth - Investing.com Nigeria

May 14, 2025
pulisher
May 13, 2025

Becton Dickinson Sues Baxter Over Infusion Pump Patents - Law360

May 13, 2025
pulisher
May 13, 2025

BD files patent infringement lawsuit against Baxter over infusion pump tech - Drug Delivery Business

May 13, 2025
pulisher
May 13, 2025

Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News

May 13, 2025
pulisher
May 13, 2025

Transcript : Baxter International Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Hurricane Helene Updates - Baxter

May 13, 2025
pulisher
May 12, 2025

Ameriprise Financial Inc. Sells 2,346,164 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

May 12, 2025
pulisher
May 10, 2025

Morgan Stanley Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat

May 10, 2025
pulisher
May 08, 2025

Baxter International Inc. (BAX) Announces Results of 2025 Annual Meeting - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Baxter International Holds 2025 Annual Meeting with Key Decisions - TipRanks

May 08, 2025
pulisher
May 08, 2025

Baxter International Inc (BAX) Shares Up 4.23% on May 8 - GuruFocus

May 08, 2025
pulisher
May 08, 2025

The 'Goldilocks' Case For Baxter International (NYSE:BAX) - Seeking Alpha

May 08, 2025
pulisher
May 08, 2025

SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

Baxter International First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus

May 07, 2025
pulisher
May 06, 2025

Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph

May 06, 2025
pulisher
May 06, 2025

Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com

May 06, 2025
pulisher
May 06, 2025

What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com

May 06, 2025
pulisher
May 06, 2025

What Are Wall Street Analysts' Target Price for Baxter International Stock? - inkl

May 06, 2025
pulisher
May 06, 2025

Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail

May 06, 2025
pulisher
May 04, 2025

Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - Defense World

May 04, 2025
pulisher
May 03, 2025

Baxter stock rises on earnings beat, guidance raise - MSN

May 03, 2025
pulisher
May 03, 2025

Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025
pulisher
May 02, 2025

Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica

May 02, 2025
pulisher
May 02, 2025

Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat

May 02, 2025
pulisher
May 02, 2025

Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st

May 02, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ... - Yahoo

May 02, 2025
pulisher
May 02, 2025

Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS Surpass Expectations - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Baxter International Reports Strong Q1 2025 Results - TipRanks

May 02, 2025

Finanzdaten der Baxter International Inc-Aktie (BAX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_instruments_supplies COO
$80.12
price down icon 0.58%
medical_instruments_supplies WST
$211.39
price up icon 0.18%
$63.71
price up icon 2.48%
$180.11
price up icon 0.87%
$72.63
price up icon 0.14%
Kapitalisierung:     |  Volumen (24h):